Navigation Links
Syngenta To Build Major Global Biotech Research Center in Beijing, China
Date:4/16/2008

BASEL, Switzerland, April 17 /PRNewswire-FirstCall/ -- Syngenta today announced that it will build a new biotech research & technology center in Beijing, China. Its focus will be on early-stage evaluation of GM and native traits for key crops such as corn and soy, in the areas of yield improvement, drought resistance, disease control and biomass conversion for biofuels. The new facility will have a global scope and will complement Syngenta's biotech research activities in the US. The investment will be approximately $65 million in the first five years.

"China is increasingly recognized for the scale and caliber of its biotech expertise in agriculture," says Dave Lawrence, Head of R&D and a member of Syngenta's Executive Committee. "Having our own research base in Beijing will accelerate innovation and offer powerful opportunities to work more closely with Chinese research institutes, which is all the more relevant now in a world that sees higher global demand for crops."

The new center, Syngenta Biotechnology (China) Co Ltd, will be built at Zhongguancun Life Science Park in Beijing. Until the new facilities are completed in 2010, adjacent temporary facilities will enable operations to commence from summer 2008. The biotech center will initially employ some 100 researchers and staff, increasing to around 200 after the new building is opened in 2010.

China is both an important producing and consuming agricultural region. Syngenta is expanding its partnerships to contribute to further growth in Chinese agriculture with seeds and crop protection technology. Earlier this month, Syngenta completed the share transaction with leading Chinese corn seeds company Sanbei Seed Co Ltd in Hebei province, in which it has taken a 49% stake. Last year, Syngenta entered into a five-year research collaboration with the Institute of Genetics and Developmental Biology (IGDB) in Beijing on the development of novel agronomic traits for key crops such as corn, soybean, wheat, sugar beet and sugar cane.

Syngenta is a world-leading agribusiness committed to sustainable agriculture through innovative research and technology. The company is a leader in crop protection, and ranks third in the high-value commercial seeds market. Sales in 2007 were approximately $9.2 billion. Syngenta employs over 21,000 people in more than 90 countries of which over 4,000 are in R&D. Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (NYSE: SYT). Further information is available at http://www.syngenta.com .

Media Enquiries: Medard Schoenmaeckers (Switzerland) +41 61 323 2323

Sarah Hull (US) +1 202 628 2372

Analysts/Investors: Jennifer Gough

Switzerland +41 61 323 5059

US +1 202 737 6521

Jonathan Seabrook

Switzerland +41 61 323 7502

US +1 202 737 6520

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.


'/>"/>
SOURCE Syngenta
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
2. Syngenta Licenses Chromatin Gene Stacking Technology
3. Roche Molecular Diagnostics Invests $57.5 Million in Green Research Building
4. Op-Ed: The NBAF Would Build on Kansas Existing Strengths in Bioscience
5. Kiwa Bio-Tech Products Group Holds Meetings to Build Distribution Network
6. ExonHit Builds A New Organisation
7. University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
8. Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
9. Siemens Building Technologies Helping Companies Participate in EPA Labs21 Movement With Comprehensive Compliance Solution Strategy
10. Microfabrica Introduces Set of Miniature Building Blocks for Minimally-Invasive Medical Devices
11. WallSt.net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):